Sugi Predict

Sugi Predict / Compounds / SCHEMBL8900690

SCHEMBL8900690

SCHEMBL8900690

O=C1CCCC2=C1CCCCCC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.38
▸ TRIM24 O15164 2/20 0.38
▸ TRIM33 Q9UPN9 2/20 0.38
▸ MAOA P21397 2/20 0.34
▸ MAOB P27338 2/20 0.34
▸ CYP2A6 P11509 1/20 0.34
▸ PLK1 P53350 1/20 0.33
▸ CSNK2A1 P68400 1/20 0.33
▸ PLK3 Q9H4B4 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ HSD17B10 Q99714 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ HTT P42858 1/20 0.32
▸ MEN1 O00255 2/20 0.30
▸ KMT2A Q03164 2/20 0.30
▸ PRKCI P41743 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5833660 1.00 ALDH1A1 (0.38) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL6151244 1.00 ALDH1A1 (0.38) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL131908 0.97 ALDH1A1 (0.40) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL5464779 0.97 TRIM24 (0.35) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL5626714 0.94 ALDH1A1 (0.33) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL6249725 0.94 TRIM24 (0.37) ALDH1A1TRIM24TRIM33SMN1; SMN2HSD17B10
SCHEMBL8350165 0.89 TRIM24 (0.38) ALDH1A1TRIM24TRIM33HSD17B10HPGD
SCHEMBL8070883 0.89 TRIM24 (0.38) ALDH1A1TRIM24TRIM33HSD17B10HPGD
SCHEMBL29540851 0.89 TRIM24 (0.38) ALDH1A1TRIM24TRIM33HSD17B10HPGD
SCHEMBL889421 0.86 TRIM24 (0.35) ALDH1A1TRIM24TRIM33HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115621554-B Electrolyte additive, electrolyte and lithium ion battery 重庆大学锂电及新材料遂宁研究院 2023-08-22 — — CN disclosed
CN-115621554-A Electrolyte additive, electrolyte and lithium ion battery 重庆大学锂电及新材料遂宁研究院 2023-01-17 — — CN disclosed
US-8188320-B2 Process for preparing pure cyclododecanone BASF SE (DE) 2012-05-29 — — US disclosed
US-8188320-B2 Process for preparing pure cyclododecanone BASF SE (DE) 2012-05-29 — — US disclosed
WO-2010086314-A1 METHOD FOR PRODUCING PURE CYCLODODECANONE BASF SE (DE) 2010-08-05 — — WO disclosed
US-20100191018-A1 PROCESS FOR PREPARING PURE CYCLODODECANONE BASF SE (DE) 2010-07-29 — — US disclosed
US-20100191018-A1 PROCESS FOR PREPARING PURE CYCLODODECANONE BASF SE (DE) 2010-07-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100191018-A1 PROCESS FOR PREPARING PURE CYCLODODECANONE CCNA1, CYC1, CCNA2 ALDH1A1 503/4885TRIM24 3392/4885TRIM33 4369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.